Department of Medicine

HemHub Seminar Series

Master
Content

Held virtually via Zoom: 11:30 a.m. - 12:15 p.m. (CST)

Zoom Link
Meeting ID:  387 923 767
Passcode:  831342

Series Schedule
DateSpeakerTitle/Presentation
Jan. 8, 2024Dr. Richard Dillon. Guy’s Hospital/King’s College, LondonFLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML
View Presentation
(BCM Login Required)
Dec. 4, 2023Claudia Haferlach, M.D., MLL-Munich Leukemia LaboratorySF3B1 mutated MDS: Blast count, genetic co-abnormalities and their impact on classification and prognosis
View Presentation
(BCM login required)
Nov. 20 , 2023Nathali Kaushansky, M.D., Weizmann Institute of ScienceInflammatory signals from fatty bone marrow support DNMT3A driven clonal hematopoiesis
Join via Zoom
Telephone: (713) 798-9666
Meeting ID: 387 923 767
Password: 831342
Nov. 6, 2023María Linares, Ph.D.,  Universidad Complutense de MadridPosttranslational splicing modifications as a key mechanism in cytarabine resistance in acute myelogenous leukemia
View Presentation
(BCM login required)
Sept. 25, 2023 Carsten Müller-Tidow, Professor of Medicine, M.D., Heidelberg University HospitalPlasticity of AML phenotypes: mechanisms and differentiation routes
View Presentation
(BCM login required)
Sept. 11, 2023  Rolf Marschalek, Ph.D., Goethe-University, Inst. Pharm Biology      Diagnosing MLL-r leukemia and behind: knowledge about the function(s) of MLL and its fusion protein
View Presentation
(BCM login required)
Aug. 21, 2023Alvin Makohon-Moore, Ph.D.
Hackensack Meridian Health Center for Discovery and Innovation Georgetown Lombardi Comprehensive Cancer Center
Quantifying past, present, and future cancer evolution
View Presentation
(BCM login required)
Aug. 7, 2023Mariusz Z. Ratajczak, M.D., Ph.D.
University of Louisville
Intracellular complement {complosome] is expressed in hematopoietic stem/progenitor cells (HSPCs) and regulates cell trafficking, metabolism and proliferation in an intracrine Nlrp3 inflammasome-dependent manner
View Presentation
(BCM login required)
July 10, 2023 Eulàlia Genescà, Ph.D.
Josep Carreras Leukaemia Research Institute (IJC)
Role of genomics in the stratification and management of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials
View Presentation
(BCM login required)
June 26, 2023Triona Ni Chonghaile, Ph.D., Associate Professor 
Royal College of Surgeons in Ireland
New insights into paths of venetoclax resistance
View Presentation
(BCM login required)
June 12, 2023Catherine Lai, M.D., MPH 
Physician Leader, Leukemia Clinical Research Unit
University of Pennsylvania 
TP53 in AML and MDS: The new (old) kind on the block
View Presentation
(BCM login required)
May 15, 2023Courtney Jones, Ph.D.
Princess Margaret Cancer Center   
Metabolic deregulated pathways to explain leukemogenesis and decreased BCL2 sensitivity in AML
May 1, 2023 Omar Abdel- Wahab, M.D.
Edward P. Evans Chair in MDS
Chair, Molecular Pharmacology Program
Sloan Kettering Institute  ​
Understanding and Targeting Altered RNA Splicing in Leukemia
View Presentation
(BCM login required)
Dec. 14, 2022Hitoshi Takizawa, Ph.D.
Vice-Director and Professor
International Research Center for Medical Sciences, Kumamoto University
Microbial signals in hematopoietic regulation
View Presentation
(BCM login required)
Nov. 7, 2022Cyrus Khandanpour, M.D.
Deputy Director and Professor, University
of Lübeck and University Hospital of Schleswig-Holstein
New Therapeutic Approaches for Leukemia
View Presentation
(BCM login required)